Navigation Links
CyberKnife to be Focus of Numerous Presentations at the American Society for Radiation Oncology (ASTRO) Annual Meeting
Date:10/30/2009

Anderson Cancer Center; Debra Freeman, M.D., from Naples Radiation Oncology; Sonja Dieterich, Ph.D., and Iris Gibbs, M.D., from Stanford University Hospital; Kim Huang, M.D., from University of California San Francisco; and Greg Spurlock from US Radiosurgery.

Accuray will be exhibiting at booth #1526. For more information on the accepted abstracts, posters and in-booth presentations related to the CyberKnife System please visit www.accuraychicago.com.

About the CyberKnife® Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 70,000 patients worldwide and currently 180 Systems have been installed in leading hospitals in the Americas, Europe and Asia. For more informati
'/>"/>

SOURCE Accuray Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Accurays Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
2. Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery
3. CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth
4. Morse CyberKnife CEO James G. Schwade, M.D. Announces Non-Surgical Treatment With CyberKnife Radiosurgery for Prostate Cancer
5. New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times
6. M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
7. London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference
8. FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics Focus Diagnostics
9. Frost & Sullivan Identifies Focus on Quality Management and Adoption of a Full-service Model as Keys to the Growth of the European CRO Market
10. Ethicon Endo-Surgery Wins Prestigious International Design Award for Innovative Development of HARMONIC FOCUS(TM)
11. Health Reform Bills Still Lack Strategic Focus on Health Workforce

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...25/PRNewswire/--TheFDAgrantedtraditionalapprovalfo...ereversetranscriptaseinhibitor(NNRTI).INTELENCEist...experiencedadultswhoareexperiencingvirologicfailur...roviral(ARV)agents.Thetraditionalapprovalisbasedon...T-2.INTELENCEiscurrentlymarketedintheU.S.byTibotec...
(Date:11/25/2009)....25/PRNewswire/--RegadoBiosciences,aprivatelyheldc...swithactivecontrolagents,announcedthatDavidMazzo,P...ay21stAnnualHealthCareConferenceattheNewYorkPalace...enat1:10pm(EST)onTuesday,December1andwillincludean...ddevelopmentprogram,theanticoagulantsystem,REG1.Th...
(Date:11/25/2009)...25/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ABAX...rebloodanalysissystems,announcedtodaythatClintSeve...tthe21stAnnualPiperJaffrayHealthCareConferenceonWe...llbeheldattheNewYorkPalaceHotelinNewYorkCity. ,...ndmarketsportablebloodanalysissystemsforuseinanyve...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation 5646 1HeartSine and Your Safety Company to Donate a Portion of Sales Proceeds to Sudden Cardiac Arrest Foundation 5646 2Lilly Surpasses Energy Efficiency Goals and Celebrates Worldwide Energy Day 5643 1Lilly Surpasses Energy Efficiency Goals and Celebrates Worldwide Energy Day 5643 2NGM Biopharmaceuticals Appoints Dr Arthur D Levinson Former Genentech CEO to its Board of Directors 5640 1NGM Biopharmaceuticals Appoints Dr Arthur D Levinson Former Genentech CEO to its Board of Directors 5640 2NGM Biopharmaceuticals Appoints Dr Arthur D Levinson Former Genentech CEO to its Board of Directors 5640 3
...ical data for potential combination,therapies and ...r,ITMN-191 exposure, BARCELONA, Spain, April 11, 2...unced today the presentation of findings from,thre... inhibitor,ITMN-191, alone or in combination with ... European Association for the Study of the,Liver i...
...IRE)--Apr 11, 2007 - New data,supporting the clini... most advanced investigational oral protease inhib... infection, will be presented,at the 42nd Annual M...f the Liver (EASL) in Barcelona this week. In tota...accepted for presentation,at the EASL conference, ...
Other Medicine Technology:InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 2InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 3InterMune Presents Research on ITMN-191 in Hepatitis C at EASL,Annual Meeting 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 2Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 3Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 4Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 5Vertex Pharmaceuticals Announces New Data for Investigational HCV,Protease Inhibitor Telaprevir to be Presented at 42nd Annual,Meeting of the European Association for the Study of the Liver,(EASL) 6
(Date:11/25/2009)...ivors of testicular cancer who were treated with c...ffects, including neurological side effects and Ra...d with chemotherapy, according to a new study publ...tional Cancer Institute . , Marianne Brydy, M.D....ity Hospital, in Bergen, Norway, and colleagues co...
(Date:11/25/2009)...-up period was too short to draw definite conclusi...5 (HealthDay News) -- In diabetic patients with bl...fference in outcomes at one year whether patients ...g, British researchers report. , Bypass surgery...ents with coronary artery disease. However, less i...
(Date:11/25/2009)...plagued by neurological symptoms, study finds , ...Neurological side effects are among the potential ...r cancer who were treated with cisplatin-based che...ncluded 1,409 Norwegian men treated for unilateral...part in a follow-up survey conducted from 1998 to ...
(Date:11/25/2009)...ImprovementShownforthe4thStraightYear ,, WASH...CancerAlliance-Georgia(LCA-GA)issuedthe 4thAnnualR...rogressbeingmadeagainstthislethaldiseaseinthestate...),theonlynationalorganizationdedicatedexclusivelyt...iskforlungcancer. ,, (Logo: http://www.newscom....
(Date:11/25/2009)...laced under the skin kill tumor cells, study finds... -- A cancer vaccine delivered in a fingernail-siz...w study reports. , The method uses polymer disk...th tumor-specific antigens and implanted under the...ors. The Harvard University scientists who develop...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...d a closely monitored surveillance for patients wi...he occurrence of cancer recurrence // compared to ...most of the hospitals. Researchers have found that... treatment and cancer survival. Researchers...
...ghanistan and Nigeria is a polio-endemic country, ...o stop the indigenous polio transmission, accordin...rget remaining strains of the virus has also been ..., namely poliovirus types 1 and 3.In 2006, monoval...
...couraging people from Hong Kong from buying poultr...raditional dish consumed during the // ar New Year...er said Hong Kong residents would ask vendors to k...three from a village in the Shataukok border area ...
...are coming to India for the sake of low priced cos...ucing the waistline, rhinoplasty, and breast impro...osmetic surgeries are conducted in the UK every ye...ic operations performed in 2005. Each breast enlar...
...adversely affected as a result of snoring, accordi...ders Center at Rush University Medical Center // i...the snoring of their husbands. This problem has al...ween the couple when one of them is deprived of sl...
...arch is on the verge of path breaking news that s...cy and schizophrenia. // Reduced vitamin D leve... could spark off the onset of this disorder, acco...el this potential link between Schizophrenia and V...
Other Medicine News:Health News:More People Come To India For Cosmetic Surgery 2Health News:Sunny Side Up - Vitamin-D deficiency linked to Schizophrenia 2
LD Lactate –> Pyruvate
Rheumatoid Factor Latex Test (RF)
IgG (sample dilution, 1-shot only) (Liquid)
CRP (Complete Kit with Disposible Cards)
Medicine Products: